UniProt ID | MIRO1_HUMAN | |
---|---|---|
UniProt AC | Q8IXI2 | |
Protein Name | Mitochondrial Rho GTPase 1 | |
Gene Name | RHOT1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 618 | |
Subcellular Localization |
Mitochondrion outer membrane Single-pass type IV membrane protein . Colocalizes with MGARP and RHOT2 at the mitochondria. |
|
Protein Description | Mitochondrial GTPase involved in mitochondrial trafficking. Probably involved in control of anterograde transport of mitochondria and their subcellular distribution.. | |
Protein Sequence | MKKDVRILLVGEPRVGKTSLIMSLVSEEFPEEVPPRAEEITIPADVTPERVPTHIVDYSEAEQSDEQLHQEISQANVICIVYAVNNKHSIDKVTSRWIPLINERTDKDSRLPLILVGNKSDLVEYSSMETILPIMNQYTEIETCVECSAKNLKNISELFYYAQKAVLHPTGPLYCPEEKEMKPACIKALTRIFKISDQDNDGTLNDAELNFFQRICFNTPLAPQALEDVKNVVRKHISDGVADSGLTLKGFLFLHTLFIQRGRHETTWTVLRRFGYDDDLDLTPEYLFPLLKIPPDCTTELNHHAYLFLQSTFDKHDLDRDCALSPDELKDLFKVFPYIPWGPDVNNTVCTNERGWITYQGFLSQWTLTTYLDVQRCLEYLGYLGYSILTEQESQASAVTVTRDKKIDLQKKQTQRNVFRCNVIGVKNCGKSGVLQALLGRNLMRQKKIREDHKSYYAINTVYVYGQEKYLLLHDISESEFLTEAEIICDVVCLVYDVSNPKSFEYCARIFKQHFMDSRIPCLIVAAKSDLHEVKQEYSISPTDFCRKHKMPPPQAFTCNTADAPSKDIFVKLTTMAMYPHVTQADLKSSTFWLRASFGATVFAVLGFAMYKALLKQR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
92 | Ubiquitination | NNKHSIDKVTSRWIP CCCCCCHHHHHCEEH | 45.82 | - | |
92 | Acetylation | NNKHSIDKVTSRWIP CCCCCCHHHHHCEEH | 45.82 | 19608861 | |
107 | Ubiquitination | LINERTDKDSRLPLI HHCCCCCCCCCCCEE | 57.92 | - | |
153 | Ubiquitination | ECSAKNLKNISELFY HHCCCCCCCHHHHHH | 62.72 | 21890473 | |
153 (in isoform 2) | Ubiquitination | - | 62.72 | 21890473 | |
153 (in isoform 3) | Ubiquitination | - | 62.72 | 21890473 | |
153 (in isoform 1) | Ubiquitination | - | 62.72 | 21890473 | |
153 (in isoform 4) | Ubiquitination | - | 62.72 | 21890473 | |
153 (in isoform 5) | Ubiquitination | - | 62.72 | 21890473 | |
153 (in isoform 6) | Ubiquitination | - | 62.72 | 21890473 | |
156 | Phosphorylation | AKNLKNISELFYYAQ CCCCCCHHHHHHHHH | 37.33 | 22078885 | |
160 | Phosphorylation | KNISELFYYAQKAVL CCHHHHHHHHHHHHC | 15.54 | - | |
182 | Ubiquitination | CPEEKEMKPACIKAL CCCHHHCHHHHHHHH | 30.47 | - | |
187 (in isoform 4) | Ubiquitination | - | 36.91 | 21890473 | |
187 (in isoform 5) | Ubiquitination | - | 36.91 | 21890473 | |
187 (in isoform 2) | Ubiquitination | - | 36.91 | 21890473 | |
187 (in isoform 1) | Ubiquitination | - | 36.91 | 21890473 | |
187 (in isoform 3) | Ubiquitination | - | 36.91 | 21890473 | |
187 (in isoform 6) | Ubiquitination | - | 36.91 | 21890473 | |
187 | Ubiquitination | EMKPACIKALTRIFK HCHHHHHHHHHHHHH | 36.91 | 2189047 | |
194 | Ubiquitination | KALTRIFKISDQDND HHHHHHHHCCCCCCC | 38.64 | - | |
194 (in isoform 2) | Ubiquitination | - | 38.64 | - | |
230 | Ubiquitination | PQALEDVKNVVRKHI HHHHHHHHHHHHHHH | 57.24 | - | |
235 | Ubiquitination | DVKNVVRKHISDGVA HHHHHHHHHHCCCCC | 33.41 | - | |
235 (in isoform 2) | Ubiquitination | - | 33.41 | - | |
276 | Phosphorylation | TVLRRFGYDDDLDLT HHHHHHCCCCCCCCC | 17.31 | 18452278 | |
283 | Phosphorylation | YDDDLDLTPEYLFPL CCCCCCCCHHHHHHH | 17.46 | 18452278 | |
298 | Phosphorylation | LKIPPDCTTELNHHA HCCCCCCCCCCCHHH | 30.59 | 22078885 | |
299 | Phosphorylation | KIPPDCTTELNHHAY CCCCCCCCCCCHHHE | 44.82 | 22078885 | |
325 | Phosphorylation | LDRDCALSPDELKDL CCCCCCCCHHHHHHH | 16.27 | 24076635 | |
330 | Ubiquitination | ALSPDELKDLFKVFP CCCHHHHHHHHHHCC | 50.79 | - | |
427 | Ubiquitination | RCNVIGVKNCGKSGV ECEEEEEECCCHHHH | 41.11 | - | |
461 | Phosphorylation | KSYYAINTVYVYGQE HHEEEEEEEEEECCE | 13.70 | 28442448 | |
463 | Phosphorylation | YYAINTVYVYGQEKY EEEEEEEEEECCEEE | 5.96 | 28152594 | |
465 | Phosphorylation | AINTVYVYGQEKYLL EEEEEEEECCEEEEE | 8.73 | 28152594 | |
512 (in isoform 3) | Ubiquitination | - | 40.26 | - | |
512 | Malonylation | EYCARIFKQHFMDSR HHHHHHHHHHCCCCC | 40.26 | 26320211 | |
512 | Acetylation | EYCARIFKQHFMDSR HHHHHHHHHHCCCCC | 40.26 | 25953088 | |
512 (in isoform 3) | Malonylation | - | 40.26 | 26320211 | |
512 | Ubiquitination | EYCARIFKQHFMDSR HHHHHHHHHHCCCCC | 40.26 | - | |
535 | Ubiquitination | KSDLHEVKQEYSISP CCCHHHHHHHHCCCH | 34.13 | - | |
558 | Phosphorylation | MPPPQAFTCNTADAP CCCCCCEECCCCCCC | 14.09 | - | |
561 | Phosphorylation | PQAFTCNTADAPSKD CCCEECCCCCCCCCC | 28.23 | - | |
566 | Phosphorylation | CNTADAPSKDIFVKL CCCCCCCCCCEEEHH | 44.68 | - | |
572 (in isoform 2) | Ubiquitination | - | 29.39 | - | |
572 | Ubiquitination | PSKDIFVKLTTMAMY CCCCEEEHHHHHHHC | 29.39 | - | |
579 | Phosphorylation | KLTTMAMYPHVTQAD HHHHHHHCCCCCHHH | 4.81 | 29116813 | |
589 (in isoform 3) | Phosphorylation | - | 41.74 | 28348404 | |
589 (in isoform 2) | Phosphorylation | - | 41.74 | 28348404 | |
589 | Phosphorylation | VTQADLKSSTFWLRA CCHHHHCCCCCHHHH | 41.74 | 27251275 | |
590 | Phosphorylation | TQADLKSSTFWLRAS CHHHHCCCCCHHHHH | 26.49 | 27251275 | |
591 | Phosphorylation | QADLKSSTFWLRASF HHHHCCCCCHHHHHH | 26.39 | 27251275 | |
597 | Phosphorylation | STFWLRASFGATVFA CCCHHHHHHCHHHHH | 20.13 | 27251275 | |
601 | Phosphorylation | LRASFGATVFAVLGF HHHHHCHHHHHHHHH | 19.28 | 27251275 | |
611 | Phosphorylation | AVLGFAMYKALLKQR HHHHHHHHHHHHHCC | 6.95 | - | |
613 (in isoform 5) | Ubiquitination | - | 10.71 | 21890473 | |
645 (in isoform 3) | Ubiquitination | - | 21890473 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MIRO1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MIRO1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PINK1_HUMAN | PINK1 | physical | 22396657 | |
PRKN_HUMAN | PARK2 | physical | 22396657 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-92, AND MASS SPECTROMETRY. |